Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Pulmonary Pharmacology & Therapeutics|June 5, 2025
Mitigating systemic corticosteroid risks in COPD: A call for earlier triple therapy initiationLuis J NanniniThe Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 26, 2019
Treat to target approach for asthmaLuis J NanniniERJ Open Research|March 2, 2023
It is time to end our love affair with short-acting β2-agonists in asthma? YesLuis J NanniniThe Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 7, 2024
Introducing the concept of loss of corticosteroid credit in asthmaLuis J NanniniPulmonary Pharmacology & Therapeutics|April 14, 2018
Overreliance link between asthmatic subjects and short-acting β2 agonistsLuis J NanniniPulmonary Pharmacology & Therapeutics|July 25, 2003
Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary diseaseLuis J Nannini, Daniela M FloresThe American Journal of Emergency Medicine|February 24, 2006
Comparison between nebulized adrenaline and beta2 agonists for the treatment of acute asthma. A meta-analysis of randomized trialsGustavo J Rodrigo, Luis J NanniniThe Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 28, 2023
Bronchodilator responsiveness testing with inhaled budesonide/formoterol in asthmaLuis J Nannini, N Brandan, O M FernándezBrain, Behavior, and Immunity|November 25, 2010
mRNA expression of alpha and beta isoforms of glucocorticoid receptor in peripheral blood mononuclear cells of patients with tuberculosis and its relation with components of the immunoendocrine responseLuciano D'Attilio, Luciano D'Attlio, Ernesto Trini, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2015
Development of a simple binary response questionnaire to identify airflow obstruction in a smoking population in ArgentinaMiguel A Bergna, Gabriel R García, Ramon Alchapar, et al.Pageof 2